About Daewoong Pharmaceutical (India) Private Limited
Data last updated: 06 January 2026
Daewoong Pharmaceutical (India) Private Limited is a foreign private limited company based in Hyderabad, Telangana, India, a subsidiary of Aewoong Pharmaceutical Co.Ltd. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 30 November 2012, the company has been in operation for over 14 years.
Registered with ROC Hyderabad under CIN U24232TG2012FTC084511.
Capital: an authorised share capital of ₹2.9 Cr and a paid-up capital of ₹2.86 Cr. It is led by directors including Neelima Aryasomayajula and Gwan Young Kim.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Plot No.5A A.P.I.I.C Kukatpally, Hyderabad, Telangana, India – 500072.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.87 Cr, a decline of 40% compared to the previous year.
The company has a workforce of approximately 23 employees as per the latest available data. It operates as a subsidiary of Aewoong Pharmaceutical Co.Ltd.
The company is associated with 1 brand - Daewoong Pharmaceutical.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website daewoong.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social MediaLocked
-
Registered AddressPlot No.5A A.P.I.I.C Kukatpally, Hyderabad, Telangana, India – 500072
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Daewoong Pharmaceutical (India) Private Limited
Daewoong Pharmaceutical (India) Private Limited has one previous CIN (Corporate Identification Number): U24232AP2012FTC084511. The current CIN is U24232TG2012FTC084511, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TG2012FTC084511 | Current |
| U24232AP2012FTC084511 | Previous |
Associated Brands with Daewoong Pharmaceutical (India) Private Limited
Daewoong Pharmaceutical (India) Private Limited operates one associated brand: Daewoong Pharmaceutical. These brands represent Daewoong Pharmaceutical (India) Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Therapies for gastrointestinal disorders and related diseases are developed. | daewoong.com |
Competitors & Alternatives of Daewoong Pharmaceutical (India) Private Limited
Brands and companies operating in the same space as Daewoong Pharmaceutical (India) Private Limited include argenx, Abzena, Zai Lab and 5 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
argenx
|
Antibody-based drugs are developed for autoimmune diseases and cancer treatment. | Ghent, Belgium, Belgium | 2008 |
Abzena
|
Provider of antibody discovery, cell line development, and bio analytics services | Cambridge, United Kingdom, United Kingdom | 2001 |
Zai Lab
|
Antibody-based therapies for cancers and inflammatory diseases are developed. | Shanghai, China, China | 2013 |
Syngene
|
Provider of contract research and manufacturing services for both small molecules and biologics | Bengaluru, India, India | 1993 |
Patheon
|
Commercial manufacturing and pharmaceutical development services for biopharmaceutical industry | Durham, United States, United States | 1974 |
MacroGenics
|
A biopharmaceutical company focused on cancer therapeutics development. | Rockville, United States, United States | 2000 |
Alexion
|
Therapies for rare and devastating diseases are developed by Alexion. | Zurich, Switzerland, Switzerland | 1992 |
Piramal Group
|
Multinational conglomerate with diverse interests in Pharma, Financial Services and Real Estate | Mumbai, India, India | 1984 |
Business Activity of Daewoong Pharmaceutical (India) Private Limited
Daewoong Pharmaceutical (India) Private Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details for Daewoong Pharmaceutical (India) Private Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Daewoong Pharmaceutical (India) Private Limited
Daewoong Pharmaceutical (India) Private Limited is audited by RAMANATHAM & RAO for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| RAMANATHAM & RAO | Locked | Locked | Locked |
Complete auditor history for Daewoong Pharmaceutical (India) Private Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Daewoong Pharmaceutical (India) Private Limited
Daewoong Pharmaceutical (India) Private Limited is currently managed by 3 directors, with 5 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Neelima Aryasomayajula
Also directs:
Daewoong Pharmaceutical (India) Private Limited
|
Additional Director | 21 May 2024 | 2 Years 3 Months | Current |
|
Gwan Young Kim
Also directs:
Daewoong Pharmaceutical (India) Private Limited
|
Director | 09 Apr 2018 | 8 Years 4 Months | Current |
| Chung Hyun Song | Director | 08 Feb 2016 | 10 Years 6 Months | Current |
Financials of Daewoong Pharmaceutical (India) Private Limited FY 2025 filings available
Daewoong Pharmaceutical (India) Private Limited reported revenue of ₹4.87 Cr (down 40.00% YoY) for FY 2025.
Ten-year financial statements for Daewoong Pharmaceutical (India) Private Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Daewoong Pharmaceutical (India) Private Limited
Shareholding and ownership data for Daewoong Pharmaceutical (India) Private Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings Daewoong Pharmaceutical (India) Private Limited
Daewoong Pharmaceutical (India) Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Daewoong Pharmaceutical (India) Private Limited
Daewoong Pharmaceutical (India) Private Limited has a workforce of 23 employees as of Mar 30, 2024.
Employee and EPFO history for Daewoong Pharmaceutical (India) Private Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Daewoong Pharmaceutical (India) Private Limited
GST registrations and filing compliance for Daewoong Pharmaceutical (India) Private Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Daewoong Pharmaceutical (India) Private Limited
Credit ratings, litigation, and regulatory alerts for Daewoong Pharmaceutical (India) Private Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Daewoong Pharmaceutical (India) Private Limited
MSME payment history for Daewoong Pharmaceutical (India) Private Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Daewoong Pharmaceutical (India) Private Limited
Corporate group structure for Daewoong Pharmaceutical (India) Private Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Daewoong Pharmaceutical (India) Private Limited
MCA filings and documents for Daewoong Pharmaceutical (India) Private Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Daewoong Pharmaceutical (India) Private Limited
Recent News on Daewoong Pharmaceutical (India) Private Limited
Frequently Asked Questions about Daewoong Pharmaceutical (India) Private Limited
Daewoong Pharmaceutical (India) Private Limited is an active foreign private limited company in the pharma sector based in Hyderabad, Telangana, India. It was incorporated on 30 November 2012 (14+ years old) and is registered under CIN U24232TG2012FTC084511. The company has 23 employees.
Daewoong Pharmaceutical (India) Private Limited reported revenue of ₹4.87 Cr for FY 2025 (down 40.00% YoY).
The current directors of Daewoong Pharmaceutical (India) Private Limited are:
- Neelima Aryasomayajula - Additional Director
- Gwan Young Kim - Director
- Chung Hyun Song - Director
The primary industry of Daewoong Pharmaceutical (India) Private Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Daewoong Pharmaceutical (India) Private Limited can be reached at the registered office: Plot No.5A A.P.I.I.C Kukatpally, Hyderabad, Telangana, India – 500072, or through the website daewoong.com.
The authorised capital is ₹2.9 Cr, and the paid-up capital is ₹2.86 Cr.